In response to stimulation (including irritants, infections, harmful airborne particles, and traumatic agents), the function of TSLP as an early mediator between cells of immunity and epithelial cells of the airways indicates that tezepelumab may normalize local inflammation through allergic and non-allergic mechanisms, regardless of blood eosinophil count. Here, TSLP is linked to infection.